FOR LABORATORY RESEARCH USE ONLY · NOT FOR HUMAN CONSUMPTION
GHRP-6PEPPUDEX

GHRP-6 · SUBTOPIC · MECHANISM

GHRP-6 Mechanism

For Laboratory Research Use Only. The mechanistic information below is descriptive of published research. No human dose is recommended. No clinical claim is made.

MECHANISM OF ACTION

Hexapeptide ghrelin receptor (GHS-R1a) agonist. Drives pituitary GH release with the strongest concomitant hunger signal in the GHRP class via direct ghrelin-mimetic activity on the arcuate nucleus.

PHARMACOKINETIC HALF-LIFE

Reported half-life for GHRP-6: ~15-60 minutes. Half-life determines the kinetic window across which receptor occupancy is maintained and frames the dosing rhythm used in published literature.

PRIMARY SEQUENCE

GHRP-6 is a defined sequence: His-D-Trp-Ala-Trp-D-Phe-Lys-NH2. Synthesis proceeds via solid-phase peptide synthesis with HPLC-verified identity confirmation.

MECHANISM CATEGORIES

GHRP-6 is tagged in 1 mechanism category on PEPPUDEX. Each category aggregates the broader pharmacology of related compounds.

The growth hormone axis is regulated by two complementary upstream signals: GHRH (stimulatory, from the hypothalamus, acting on the GHRH receptor on pituitary somatotrophs) and ghrelin (stimulatory, from the stomach, acting on the GHS-R1a). Research peptides target both arms: GH-axis reference and CJC-1295 (GHRH analogs); ipamorelin, GHRP-6, and hexarelin (ghrelin-receptor agonists).

MECHANISTIC OUTCOMES IN LITERATURE

The following outcomes are the mechanistic endpoints reported in the peer-reviewed literature, with PEPPUDEX evidence grades. Grades reflect study quality and replication, not clinical recommendation.

Selective GHS-R1a activationGRADE A

Well-characterized GHS-R1a binding (Bowers 1991). The historic prototype that established the GH-releasing peptide class.

Appetite stimulation (rodent + human)GRADE B

Strongest appetite signal in the GHRP class via direct ghrelin-mimetic activity on arcuate nucleus neurons.

Long-term GH-axis outcomes (human)GRADE D

No completed long-term Phase 3 trials.

MECHANISM Q+A

What is GHRP-6?

GHRP-6 is a synthetic hexapeptide ghrelin / GHS-R1a receptor agonist · the historic prototype that established the GH-releasing peptide class. Bowers 1991 first characterized its GH-releasing activity. Strongest appetite stimulation in the GHRP class.

GHRP-6 vs GHRP-2 · what's the difference?

Both are hexapeptide ghrelin receptor agonists. GHRP-6 has the strongest appetite signal in the GHRP class via direct ghrelin-mimetic activity. GHRP-2 has lower appetite signal due to differential downstream signaling. Both produce mild cortisol and prolactin elevation alongside the GH pulse.

GHRP-6 vs ipamorelin · which is better?

Ipamorelin is selective (no significant cortisol/prolactin/appetite elevation). GHRP-6 is non-selective with stronger appetite signal and mild stress-hormone elevation. Ipamorelin has the cleaner profile; GHRP-6 is preferred only when appetite stimulation is part of the research design.

Why does GHRP-6 cause hunger?

GHRP-6 is a direct ghrelin mimetic at the GHS-R1a receptor on arcuate-nucleus AgRP/NPY neurons. Activation of these neurons drives appetite stimulation as the canonical downstream effect of ghrelin signaling. Newer GHS like ipamorelin engage GHS-R1a with biased signaling that minimizes the appetite arm.

What is the half-life of GHRP-6?

Approximately 15-60 minutes plasma half-life. Multiple daily administrations are needed for sustained GH-axis stimulation in research protocols.

CITED LITERATURE

  • Bowers CY, Momany FA, Reynolds GA, Hong A. On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology 1984. link
  • Smith RG, Van der Ploeg LH, Howard AD, et al.. Peptidomimetic regulation of growth hormone secretion. Endocr Rev 1997. link

RELATED PAGES

GHRP-6 OVERVIEWDOSING LITERATURE ▶SAFETY PROFILE ▶

▶ LAST UPDATED · 2026-05-25

© 2026 Peppu Studio LLC · For Laboratory Research Use Only